TECHNOLOGY/BUSINESS OPPORTUNITY Automated High Throughput Screening Platform

The Department of Energy, through the Lawrence Livermore National Laboratory (LLNL), is offering a collaboration opportunity to further develop an Automated High Throughput Screening Platform designed for rapid evaluation of in silico designed antibodies. This initiative aims to enhance the efficiency of antibody development by integrating cell-free protein synthesis, microencapsulation, and optical interrogation into a single automated system, significantly reducing the experimental evaluation time from several weeks to approximately three days. The technology has broad applications in various fields, including antibody development and protein interactions, and is currently at Technology Readiness Level 2. Interested companies are encouraged to submit a statement of interest, including their corporate expertise and contact information, to LLNL's Innovation and Partnerships Office by email or written correspondence. For further details, contact Yash Vaishnav at vaishnav1@llnl.gov or Charlotte Eng at eng23@llnl.gov.